Cochlear Limited

ASX:COH Stock Report

Market Cap: AU$18.7b

Cochlear Valuation

Is COH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of COH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: COH (A$285.05) is trading above our estimate of fair value (A$233.43)

Significantly Below Fair Value: COH is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for COH?

Other financial metrics that can be useful for relative valuation.

COH key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue8.2x
Enterprise Value/EBITDA33.2x
PEG Ratio4.6x

Price to Earnings Ratio vs Peers

How does COH's PE Ratio compare to its peers?

The above table shows the PE ratio for COH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average28.1x
SHL Sonic Healthcare
25x11.0%AU$12.8b
RHC Ramsay Health Care
35.5x19.3%AU$9.0b
AHC Austco Healthcare
13.4xn/aAU$94.7m
ANN Ansell
38.4x22.8%AU$4.5b
COH Cochlear
52.3x11.4%AU$18.7b

Price-To-Earnings vs Peers: COH is expensive based on its Price-To-Earnings Ratio (52.3x) compared to the peer average (28.1x).

Price to Earnings Ratio vs Industry

How does COH's PE Ratio compare vs other companies in the Global Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.0%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.0%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: COH is expensive based on its Price-To-Earnings Ratio (52.3x) compared to the Global Medical Equipment industry average (26.8x).

Price to Earnings Ratio vs Fair Ratio

What is COH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

COH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio52.3x
Fair PE Ratio35.6x

Price-To-Earnings vs Fair Ratio: COH is expensive based on its Price-To-Earnings Ratio (52.3x) compared to the estimated Fair Price-To-Earnings Ratio (35.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst COH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$285.05
AU$290.87
+2.0%
10.1%AU$345.00AU$225.00n/a14
Oct ’25AU$291.42
AU$287.37
-1.4%
10.7%AU$345.00AU$225.00n/a14
Sep ’25AU$300.37
AU$283.49
-5.6%
11.7%AU$345.00AU$225.00n/a15
Aug ’25AU$344.57
AU$287.17
-16.7%
13.8%AU$365.00AU$220.00n/a15
Jul ’25AU$322.56
AU$280.94
-12.9%
13.2%AU$365.00AU$220.00n/a16
Jun ’25AU$322.56
AU$280.94
-12.9%
13.2%AU$365.00AU$220.00n/a16
May ’25AU$317.17
AU$280.94
-11.4%
13.2%AU$365.00AU$220.00n/a16
Apr ’25AU$337.52
AU$282.20
-16.4%
12.9%AU$365.00AU$220.00n/a17
Mar ’25AU$336.50
AU$281.02
-16.5%
13.5%AU$365.00AU$220.00n/a17
Feb ’25AU$304.87
AU$254.43
-16.5%
13.1%AU$318.46AU$200.00n/a16
Jan ’25AU$298.67
AU$251.45
-15.8%
12.2%AU$318.46AU$200.00n/a17
Dec ’24AU$272.29
AU$241.65
-11.3%
10.6%AU$295.00AU$197.78n/a18
Nov ’24AU$244.27
AU$239.49
-2.0%
9.3%AU$280.00AU$197.78AU$285.0518
Oct ’24AU$255.32
AU$238.98
-6.4%
9.6%AU$280.00AU$197.78AU$291.4218
Sep ’24AU$268.50
AU$238.25
-11.3%
9.8%AU$280.00AU$190.00AU$300.3719
Aug ’24AU$238.87
AU$226.67
-5.1%
9.1%AU$265.00AU$190.00AU$344.5719
Jul ’24AU$229.07
AU$225.49
-1.6%
9.1%AU$265.00AU$190.00AU$322.5619
Jun ’24AU$248.25
AU$225.20
-9.3%
9.2%AU$265.00AU$190.00AU$322.5619
May ’24AU$246.34
AU$224.13
-9.0%
8.9%AU$265.00AU$190.00AU$317.1716
Apr ’24AU$236.69
AU$224.13
-5.3%
8.9%AU$265.00AU$190.00AU$337.5216
Mar ’24AU$223.41
AU$222.06
-0.6%
8.0%AU$250.63AU$190.00AU$336.5017
Feb ’24AU$212.50
AU$216.05
+1.7%
9.9%AU$247.00AU$173.00AU$304.8716
Jan ’24AU$204.12
AU$215.68
+5.7%
10.4%AU$247.00AU$167.00AU$298.6716
Dec ’23AU$213.00
AU$215.62
+1.2%
10.4%AU$247.00AU$167.00AU$272.2916
Nov ’23AU$200.66
AU$214.70
+7.0%
10.2%AU$247.00AU$167.00AU$244.2717

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y